APRE Insider Trading
Clear Creek Independent School District | Pharmaceutical Preparations
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Clear Creek Independent School District provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 00:08 | 2026-01-30 | Gilad Oren | Director, Officer - President/CEO | BUY | $0.89 | 28,100 | $25,009 | 373,720 | +8.1% |
| 2026-02-03 00:05 | 2026-01-30 | Hamill John P. | Officer - SrVP/CFO/Prin Fin & Acct Ofcr | BUY | $0.89 | 5,700 | $5,073 | 33,433 | +20.6% |
| 2025-12-11 16:31 | 2025-12-10 | Duey Marc | Director | BUY | $1.17 | 21,459 | $25,000 | 256,155 | +9.1% |
| 2025-12-11 16:31 | 2025-12-10 | Hamill John P. | Officer - SrVP/CFO/Prin Fin & Acct Ofcr | BUY | $1.17 | 5,000 | $5,825 | 27,733 | +22.0% |
| 2025-04-04 14:30 | 2025-04-03 | Gilad Oren | Director, Officer - President/CEO | BUY | $1.84 | 5,500 | $10,110 | 345,620 | +1.6% |
| 2024-10-26 00:42 | 2024-10-18 | Duey Marc | Director | SELL | $4.58 | 6,462 | $29,583 | 233,651 | -2.7% |
| 2024-10-24 15:30 | 2024-10-23 | Gilad Oren | Director, Officer - President/CEO | BUY | $3.92 | 500 | $1,958 | 333,395 | +0.2% |
| 2024-10-17 15:30 | 2024-10-16 | Duey Marc | Director | BUY | $4.39 | 30,000 | $131,700 | 240,113 | +14.3% |
| 2024-10-16 15:31 | 2024-10-15 | Gilad Oren | Director, Officer - President/CEO | BUY | $2.90 | 250 | $725 | 332,895 | +0.1% |
| 2024-10-16 15:30 | 2024-10-14 | Duey Marc | Director | BUY | $2.58 | 190 | $490 | 210,113 | +0.1% |
| 2024-10-16 15:30 | 2024-10-11 | Hamill John P. | Officer - SrVP/CFO/Prin Fin & Acct Ofcr | BUY | $2.46 | 50 | $123 | 19,368 | +0.3% |
| 2024-10-15 15:31 | 2024-10-11 | Seizinger Bernd R. | Director | BUY | $2.68 | 10,000 | $26,800 | 44,730 | +28.8% |
| 2024-10-15 15:31 | 2024-10-10 | Gilad Oren | Director, Officer - President/CEO | BUY | $2.58 | 1,150 | $2,971 | 332,645 | +0.3% |
| 2024-10-15 15:30 | 2024-10-10 | Hamill John P. | Officer - SrVP/CFO/Prin Fin & Acct Ofcr | BUY | $2.61 | 450 | $1,175 | 19,318 | +2.4% |
| 2024-03-15 03:53 | 2024-03-13 | Seizinger Bernd R. | Director | BUY | $7.29 | 6,860 | $50,009 | 33,685 | +25.6% |
| 2024-03-15 03:51 | 2024-03-13 | Gilad Oren | Director, Officer - President, CEO | BUY | $7.29 | 2,000 | $14,580 | 324,770 | +0.6% |
| 2024-03-15 03:54 | 2024-03-13 | Hamill John P. | Officer - SrVP/CFO/Prin Fin & Acct Ofcr | BUY | $7.29 | 1,010 | $7,363 | 15,503 | +7.0% |
| 2024-03-15 03:52 | 2024-03-13 | HENNEMAN JOHN B III | Director | BUY | $7.29 | 6,860 | $50,009 | 8,139 | +536.4% |
| 2023-06-08 23:34 | 2023-06-06 | Seizinger Bernd R. | Director | BUY | $3.66 | 10,097 | $36,957 | 26,325 | +62.2% |
| 2022-05-19 23:31 | 2022-05-18 | Seizinger Bernd R. | Director | BUY | $0.71 | 50,000 | $35,500 | 318,580 | +18.6% |
| 2022-05-19 23:30 | 2022-05-18 | SCHADE CHRISTIAN S | Director, Officer - Chairman & CEO | BUY | $0.64 | 37,500 | $24,124 | 292,616 | +14.7% |
| 2022-03-02 01:01 | 2022-02-28 | Attar Eyal C. | Officer - SVP, Chief Medical Officer | SELL | $1.73 | 36,000 | $62,280 | 47,000 | -43.4% |
| 2021-12-04 01:01 | 2021-12-01 | Korbel Gregory Alan | Officer - SVP, Chief Business Officer | OPT+S | $3.96 | 27,500 | $108,900 | 17,167 | 0.0% |
| 2021-11-04 00:34 | 2021-11-01 | Korbel Gregory Alan | Officer - SVP, Chief Business Officer | OPT+S | $5.00 | 27,500 | $137,500 | 17,167 | 0.0% |
| 2021-10-06 00:01 | 2021-10-01 | Abrahmsen Lars B. | Officer - SVP, Chief Scientific Officer | OPT+S | $4.89 | 50,000 | $244,500 | 19,000 | 0.0% |
| 2021-10-06 00:01 | 2021-10-01 | Korbel Gregory Alan | Officer - SVP, Chief Business Officer | OPT+S | $4.89 | 27,500 | $134,475 | 17,167 | 0.0% |
| 2021-09-23 00:01 | 2021-09-20 | Korbel Gregory Alan | Officer - SVP, Chief Business Officer | OPT+S | $4.97 | 32,960 | $163,867 | 17,167 | 0.0% |
| 2021-09-23 00:00 | 2021-09-20 | Abrahmsen Lars B. | Officer - SVP, Chief Scientific Officer | OPT+S | $4.97 | 25,000 | $124,250 | 19,000 | 0.0% |
| 2021-09-21 00:29 | 2021-09-16 | Attar Eyal C. | Officer - SVP, Chief Medical Officer | SELL | $4.68 | 15,968 | $74,730 | 83,000 | -16.1% |
| 2021-02-17 00:11 | 2020-12-28 | Redmile Group, LLC | 10% owner | SELL | $5.58 | 500,000 | $2,791,300 | 1,768,718 | -22.0% |
| 2020-10-08 04:30 | 2020-10-05 | 5AM Ventures IV, L.P. | Other | SELL | $25.30 | 175,000 | $4,427,500 | 138,497 | -55.8% |
| 2020-07-08 00:41 | 2020-07-07 | KDev Investments AB | 10% owner | SELL | $34.55 | 241,703 | $8,350,839 | 1,992,586 | -10.8% |
| 2020-06-19 02:22 | 2020-06-16 | 5AM Ventures IV, L.P. | 10% owner | SELL | $33.30 | 140,000 | $4,662,000 | 313,497 | -30.9% |
| 2020-06-19 02:23 | 2020-06-16 | ROCKLAGE SCOTT M | Director, 10% owner | SELL | $33.30 | 120,164 | $4,001,461 | 75,965 | -61.3% |
| 2020-06-16 04:12 | 2020-06-11 | 5AM Ventures IV, L.P. | 10% owner | SELL | $28.75 | 245,000 | $7,044,412 | 80,772 | -75.2% |
| 2020-06-16 04:13 | 2020-06-11 | ROCKLAGE SCOTT M | Director, 10% owner | SELL | $28.75 | 245,000 | $7,044,412 | 80,772 | -75.2% |
| 2020-05-22 04:31 | 2020-05-19 | 5AM Ventures IV, L.P. | 10% owner | SELL | $35.15 | 255,000 | $8,963,250 | 90,572 | -73.8% |
| 2020-05-22 04:32 | 2020-05-19 | ROCKLAGE SCOTT M | Director | SELL | $35.15 | 255,000 | $8,963,250 | 90,572 | -73.8% |
| 2020-04-15 16:18 | 2020-04-13 | KDev Investments AB | 10% owner | SELL | $31.25 | 210,548 | $6,579,625 | 2,234,289 | -8.6% |
| 2019-10-10 01:23 | 2019-10-07 | 5AM Ventures IV, L.P. | 10% owner | BUY | $15.00 | 333,333 | $4,999,995 | 333,333 | +100.0% |
| 2019-10-09 03:13 | 2019-10-07 | Redmile Group, LLC | 10% owner | BUY | $15.00 | 400,000 | $6,000,000 | 2,268,718 | +21.4% |
| 2019-10-08 02:21 | 2019-10-07 | Korbel Gregory Alan | Officer - VP of Business Dev't | BUY | $15.00 | 500 | $7,500 | 500 | +100.0% |
| 2019-10-08 02:18 | 2019-10-07 | Attar Eyal C. | Officer - SVP, Chief Medical Officer | BUY | $15.00 | 400 | $6,000 | 200 | +100.0% |
| 2019-10-08 02:40 | 2019-10-07 | Versant Vantage I, L.P. | 10% owner | BUY | $15.00 | 333,333 | $4,999,995 | 333,333 | +100.0% |
| 2019-10-08 02:53 | 2019-10-07 | HealthCap VII, L.P. | 10% owner | BUY | $15.00 | 266,667 | $4,000,005 | 2,366,104 | +12.7% |
| 2019-10-08 02:15 | 2019-10-07 | Coiante Scott M | Officer - SVP, Chief Financial Officer | BUY | $15.00 | 2,500 | $37,500 | 2,500 | +100.0% |
| 2019-10-08 02:39 | 2019-10-07 | Versant V Luxco S.a r.l. | 10% owner | BUY | $15.00 | 333,333 | $4,999,995 | 333,333 | +100.0% |
| 2019-10-08 02:33 | 2019-10-07 | Christenson Johan | Director | BUY | $15.00 | 266,667 | $4,000,005 | 2,366,104 | +12.7% |
| 2019-10-08 02:25 | 2019-10-07 | Magni Guido | Director | BUY | $15.00 | 6,500 | $97,500 | 6,500 | +100.0% |
| 2019-10-08 02:15 | 2019-10-07 | SCHADE CHRISTIAN S | Director, Officer - President & CEO | BUY | $15.00 | 11,000 | $165,000 | 5,000 | +100.0% |
How to Interpret $APRE Trades
Not every insider transaction in Clear Creek Independent School District is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $APRE shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for APRE
Insider activity data for Clear Creek Independent School District is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $APRE, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.